|
CENPN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.742490E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.355800E-02 |
| Normal-vs-Stage2 |
6.252300E-02 |
| Normal-vs-Stage3 |
8.140400E-03 |
| Normal-vs-Stage4 |
5.377200E-03 |
| Stage1-vs-Stage2 |
7.763800E-01 |
| Stage1-vs-Stage3 |
1.661210E-01 |
| Stage1-vs-Stage4 |
8.665800E-02 |
| Stage2-vs-Stage3 |
4.991200E-01 |
| Stage2-vs-Stage4 |
2.895200E-01 |
| Stage3-vs-Stage4 |
5.107200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.784200E-02 |
| Normal-vs-AfricanAmerican |
6.039300E-04 |
| Normal-vs-Asian |
2.462400E-01 |
| Caucasian-vs-AfricanAmerican |
1.481540E-02 |
| Caucasian-vs-Asian |
1.829980E-01 |
| AfricanAmerican-vs-Asian |
3.682400E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.716400E-03 |
| Normal-vs-Female |
2.606300E-02 |
| Male-vs-Female |
3.410600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.097240E-01 |
| Normal-vs-Age(41-60Yrs) |
2.215300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.802320E-02 |
| Normal-vs-Age(81-100Yrs) |
7.789600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.360700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.381620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.625600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.298800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.375240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.837600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.738400E-02 |
| Classical-VS-Follicular |
4.292000E-02 |
| Classical-VS-Other |
1.655370E-01 |
| Classical-VS-Normal |
5.560300E-02 |
| Tall-VS-Follicular |
5.883600E-01 |
| Tall-VS-Other |
6.588800E-01 |
| Tall-VS-Normal |
2.737500E-03 |
| Follicular-VS-Other |
4.885800E-01 |
| Follicular-VS-Normal |
4.716000E-03 |
| Other-VS-Normal |
8.454400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.174000E-02 |
| Normal-vs-N1 |
1.509550E-02 |
| N0-vs-N1 |
5.025800E-01 |
|
|
